Zhenjun Gu

Dr. Zhenjun Gu


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2026 in Forests
Verified
Journal Article
Open access
PDF file
GZGuang Zhou
Guang Zhou
JWJing Wan
Jing Wan
BGBin Gong
Bin Gong
ZGZhenjun Gu
Zhenjun Gu
WDWei Ding
Wei Ding
CYChunxia Yang
Chunxia Yang
Slash pine plantations managed jointly for timber and oleoresin require fertilization regimes that support both stem growth and resin production. We conducted a two-year field experiment in a 14-year-old, newly tapped Pinus elliottii plantation in subtropical Jiangxi, China, comprising an unfertilized control (CK) and nine fertilization treatments representing three nitrogen (N) rates, three phosphorus (P) rates, and three compound-fertilizer formulations (three 20 × 20 m plots per treatment). Fertilizers were applied in spring 2022 and 2023. Relative to CK, the two highest P rates increased the 2022–2023 DBH increment by 0.71–0.74 cm (Dunnett’s test, p < 0.05), and DBH and volume increments increased linearly with P rate, although the overall treatment effect on increments was marginal (p = 0.080–0.112). In 2023, resin yield was 20.6%–25.7% higher than in CK under all three N rates, the highest P rate, and the highest compound formulation (p < 0.05), and treatment effects remained significant after adjusting for stem basal area. Growth and total resin yield did not differ significantly between the N-only and P-only series, whereas resin yield per unit basal area was higher under N than under P fertilization (p = 0.022). Soil variables explained 50.6% of the variation in needle traits (adjusted R2 = 0.20; p = 0.004). Stem growth was correlated with soil total and available P, soil Cu, and needle P, whereas resin yield was correlated with soil available B and needle N. These associations identify candidate nutrient constraints for dual-purpose slash pine management that should be tested in factorial, multi-site trials.